Dr. Carter Davis, MD
NPI: 1407146418
Total Payments
$45,968
2024 Payments
$19,704
Companies
32
Transactions
135
Medicare Patients
1,327
Medicare Billing
$221,356
Payment Breakdown by Category
Consulting$33,234 (72.3%)
Food & Beverage$5,916 (12.9%)
Travel$4,533 (9.9%)
Other$2,070 (4.5%)
Education$215.26 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $33,234 | 19 | 72.3% |
| Food and Beverage | $5,916 | 96 | 12.9% |
| Travel and Lodging | $4,533 | 15 | 9.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,070 | 1 | 4.5% |
| Education | $215.26 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech, Inc. | $10,315 | 12 | $0 (2024) |
| ABBVIE INC. | $7,947 | 20 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $7,670 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $6,678 | 8 | $0 (2024) |
| SERVIER PHARMACEUTICALS LLC | $2,638 | 3 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $2,146 | 2 | $0 (2023) |
| Genentech USA, Inc. | $1,936 | 3 | $0 (2024) |
| Celgene Corporation | $1,400 | 13 | $0 (2024) |
| Janssen Biotech, Inc. | $1,111 | 3 | $0 (2023) |
| TAIHO ONCOLOGY, INC. | $1,100 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,704 | 54 | ABBVIE INC. ($7,742) |
| 2023 | $16,179 | 35 | Genentech, Inc. ($5,679) |
| 2022 | $8,769 | 24 | Genentech, Inc. ($4,542) |
| 2021 | $129.16 | 2 | Seagen Inc. ($99.97) |
| 2020 | $354.27 | 5 | Jazz Pharmaceuticals Inc. ($259.04) |
| 2019 | $120.67 | 7 | Celgene Corporation ($51.22) |
| 2018 | $699.67 | 7 | Amgen Inc. ($243.53) |
| 2017 | $13.23 | 1 | Janssen Biotech, Inc. ($13.23) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $92.19 | General |
| 12/08/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 12/07/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $71.63 | General |
| 12/06/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $94.96 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $136.11 | General |
| Category: CELLT | ||||||
| 11/14/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $31.01 | General |
| Category: Oncology | ||||||
| 11/01/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Oncology | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $370.50 | General |
| 09/19/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $123.96 | General |
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,482.00 | General |
| 08/06/2024 | Janssen Scientific Affairs, LLC | TECVAYLI (Biological), DARZALEX, TALVEY | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: Oncology | ||||||
| 07/21/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $49.47 | General |
| 07/19/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $97.61 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $23.58 | General |
| 06/27/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $85.03 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $86.67 | General |
| Category: Hematology | ||||||
| 06/21/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,636.00 | General |
| 06/21/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,636.00 | General |
| 06/21/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $329.50 | General |
| 06/21/2024 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $46.00 | General |
| 06/21/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $14.93 | General |
| 06/21/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $6.66 | General |
| 06/05/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 323 | 654 | $183,885 | $59,337 |
| 2022 | 8 | 305 | 680 | $196,038 | $64,872 |
| 2021 | 7 | 293 | 569 | $149,757 | $48,915 |
| 2020 | 10 | 406 | 687 | $174,220 | $48,232 |
Total Patients
1,327
Total Services
2,590
Medicare Billing
$221,356
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 69 | 197 | $62,881 | $20,246 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 105 | 170 | $40,190 | $11,799 | 29.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 118 | $27,258 | $10,951 | 40.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 56 | $22,504 | $7,150 | 31.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 19 | $8,512 | $2,463 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 35 | 44 | $7,232 | $1,999 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 18 | 18 | $6,648 | $1,780 | 26.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 12 | 12 | $5,460 | $1,706 | 31.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 20 | $3,200 | $1,242 | 38.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 86 | 269 | $85,993 | $29,967 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 87 | 155 | $37,265 | $10,709 | 28.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 124 | $28,644 | $10,068 | 35.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 43 | $16,943 | $5,654 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 25 | 25 | $9,175 | $2,660 | 29.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 14 | 14 | $6,370 | $2,072 | 32.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 12 | $5,376 | $1,886 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 17 | 21 | $3,552 | $955.47 | 26.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 17 | $2,720 | $901.34 | 33.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 60 | 132 | $42,132 | $14,543 | 34.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 95 | 196 | $46,780 | $14,319 | 30.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 37 | 128 | $29,568 | $10,539 | 35.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 30 | 30 | $10,980 | $3,114 | 28.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 15 | $6,720 | $2,417 | 36.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 19 | $5,545 | $1,666 | 30.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 33 | 35 | $5,792 | $1,509 | 26.1% |
About Dr. Carter Davis, MD
Dr. Carter Davis, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2011. The National Provider Identifier (NPI) number assigned to this provider is 1407146418.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carter Davis, MD has received a total of $45,968 in payments from pharmaceutical and medical device companies, with $19,704 received in 2024. These payments were reported across 135 transactions from 32 companies. The most common payment nature is "Consulting Fee" ($33,234).
As a Medicare-enrolled provider, Davis has provided services to 1,327 Medicare beneficiaries, totaling 2,590 services with total Medicare billing of $221,356. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Hematology & Oncology
- Location New Orleans, LA
- Active Since 04/11/2011
- Last Updated 07/26/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1407146418
Products in Payments
- VENCLEXTA (Drug) $7,444
- Venclexta (Biological) $5,654
- VENCLEXTA (Biological) $4,392
- Tibsovo (Drug) $2,638
- Tazverik (Drug) $2,070
- POLIVY (Biological) $1,765
- IMBRUVICA (Drug) $1,123
- INQOVI (Drug) $1,100
- REBLOZYL (Biological) $292.24
- ADCETRIS (Biological) $289.06
- VYXEOS (Drug) $259.04
- Yescarta (Drug) $199.57
- BRUKINSA (Drug) $176.05
- DARZALEX (Biological) $158.18
- ONUREG (Drug) $125.00
- Prolia (Biological) $125.00
- Stivarga (Drug) $124.99
- Columvi (Biological) $119.19
- Kyprolis (Biological) $118.53
- Poteligeo (Drug) $116.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in New Orleans
Dr. Rima El-Abassi, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $255,887
Student in an Organized Health Care Education/Training Program $255,887
Dr. Patrick Greiffenstein, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $214,722
Student in an Organized Health Care Education/Training Program $214,722
Veronica Gillispie, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $126,771
Student in an Organized Health Care Education/Training Program $126,771
Michael Bernard, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $121,414
Student in an Organized Health Care Education/Training Program $121,414
Nicole Lapinel, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $114,205
Student in an Organized Health Care Education/Training Program $114,205
Lingling Du, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $94,740
Student in an Organized Health Care Education/Training Program $94,740